SkyView Investment Advisors, LLC - EUCRATES BIOMEDICAL ACQU COR ownership

Quarter-by-quarter ownership
SkyView Investment Advisors, LLC ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q1 2023$728
+1.5%
71,7730.0%0.17%
-21.7%
Q4 2022$717
-99.9%
71,7730.0%0.22%
+3.3%
Q3 2022$719,000
+1.3%
71,7730.0%0.21%
+12.3%
Q2 2022$710,000
+0.6%
71,7730.0%0.19%
+12.0%
Q1 2022$706,000
+0.7%
71,7730.0%0.17%
+5.7%
Q4 2021$701,000
+7.8%
71,773
+8.0%
0.16%
-13.7%
Q3 2021$650,00066,4630.18%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q2 2023
NameSharesValueWeighting ↓
Altium Capital Management LP 400,000$4,008,0001.47%
683 Capital Management, LLC 600,000$6,012,0000.46%
CVI Holdings, LLC 367,552$3,687,0000.29%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$2,004,0000.26%
SkyView Investment Advisors, LLC 71,773$719,0000.21%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 999,999$10,020,0000.20%
GLAZER CAPITAL, LLC 1,022,411$10,245,0000.19%
METEORA CAPITAL, LLC 56,076$562,0000.14%
Cowen Investment Management LLC 50,000$501,0000.11%
First Trust Capital Management L.P. 208,598$2,090,0000.10%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders